![goback](data:image/svg+xml;charset=utf-8,<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 20"><path d="M10,0l2,2l-8,8l8,8l-2,2L0,10L10,0z" fill="%23fff"/></svg>){kind=icon}
Therapeutic Advances in Hematology
期刊信息导读
- Therapeutic Advances in Hematology基本信息
- Therapeutic Advances in Hematology中科院SCI期刊分区
- 历年Therapeutic Advances in Hematology影响因子趋势图
- Therapeutic Advances in Hematology期刊英文简介
- Therapeutic Advances in Hematology期刊中文简介
Therapeutic Advances in Hematology基本信息
简称：THER ADV HEMATOL
中文名称：血液学治疗进展
是否OA开放访问：No
PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2040-6207%5BISSN%5D
Therapeutic Advances in Hematology期刊英文简介
Therapeutic Advances in Hematology (TAH) is a peer-reviewed open access journal which focuses on delivering the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of hematology. Please see the Aims and Scope tab for further information.
Therapeutic Advances in Hematology期刊中文简介
《血液学治疗进展》(TAH)是一份经过同行评审的开放获取期刊，专注于发表高质量的同行评审文章、评论，并对血液学各个领域的开创性努力和创新研究发表学术评论。更多信息请参见Aims和Scope选项卡。
中科院SCI期刊分区：
Therapeutic Advances in Hematology影响因子
